Plan your Attendance

Learn more about SIU 2023 and plan your trip. 

Registration

Online registration is now open!

Housing 

For housing options and to book your accommodation click here.

Scientific Programme

Discover the one-of-a-kind dynamic programme here.

In conjunction with the 5th Bench-to-Bedside Uro-Oncology GU Cancers Triad Meeting, Friday, October 13. 

Partnership Opportunities

Learn more about sponsorship opportunities and exhibit information.

2023 Congress Learning Objectives

  • Understand the latest advances in the diagnosis, staging and management of urologic cancers.
  • Incorporate new techniques in robotic and minimally invasive surgery.
  • Detail the medical and surgical management of lower urinary tract dysfunction.
  • Describe the imaging evaluation and medical and surgical therapy of urinary stone disease.
  • Define the assessment and management of male infertility.
  • Characterize the surgical and medical treatment options for erectile dysfunction.
  • Examine the latest advances in reconstructive surgery including transgender surgery, urinary diversion and urethroplasty.
  • Learn how to serve the diverse healthcare needs of our international population in a patient-centered manner.
  • Learn the latest urologic sub-specialty advances occurring in the past year to augment one’s practice.
  • Provide mentoring sessions to facilitate knowledge about career opportunities and advancement for urology trainees.
  • Enumerate common urological problems of the elderly and specific precautions in their care.
  • Understand the challenges and facilitate inclusion and opportunities for underrepresented groups in urology.
  • Characterize the indications and data for new prostate cancer and bladder cancer imaging modalities.
  • Provide mentoring opportunities and guidance for urologic trainees.
  • Understand the concept of transitional urologic care for teens and young adults.
  • Enumerate the common pediatric urologic problems and understand the assessment and management of pediatric population.

 

 

Follow Us